Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-23-001061
Filing Date
2023-08-14
Accepted
2023-08-14 16:30:37
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20230630.htm   iXBRL 10-Q 1275798
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12954
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 7268
  Complete submission text file 0001753926-23-001061.txt   6302468

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20230630_def.xml EX-101.DEF 181653
3 PRESENTATION tlcc-20230630_pre.xml EX-101.PRE 326190
4 CALCULATION tlcc-20230630_cal.xml EX-101.CAL 66385
5 LABEL tlcc-20230630_lab.xml EX-101.LAB 566949
6 SCHEMA tlcc-20230630.xsd EX-101.SCH 43880
50 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20230630_htm.xml XML 1065660
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 231170937
SIC: 2833 Medicinal Chemicals & Botanical Products